Our Pricing

Aciclovir BNF Interactions and Safety Guidelines UK

Understanding aciclovir bnf interactions uk is essential for safe and effective cold sore treatment. At Cured Pharmacy, our UK-registered clinical team provides comprehensive guidance on aciclovir use, helping you navigate potential drug interactions and contraindications based on current British National Formulary recommendations.

Understanding Aciclovir BNF Classification and Mechanism

Aciclovir is classified in the BNF under section 5.3.2.1 as a nucleoside analogue antiviral agent licensed for the treatment of herpes simplex infections, including cold sores [1]. The medication works by inhibiting viral DNA polymerase, effectively preventing the herpes simplex virus from replicating in infected cells.

Available in both topical cream formulations (5% strength) and oral tablet forms, aciclovir demonstrates high selectivity for virus-infected cells, which contributes to its favourable safety profile when used appropriately [1]. The BNF notes that topical aciclovir is most effective when applied at the first sign of a cold sore outbreak, ideally during the prodromal tingling phase.

Clinical studies demonstrate that early application of aciclovir cream can reduce healing time by approximately 0.5 to 1 day compared to placebo, whilst oral formulations may provide greater benefit in severe or recurrent cases [2]. Both formulations are available at Cured Pharmacy, with our Numark Cold Sore Cream starting from £4.49, offering genuine UK-licensed treatment with transparent pricing.

Key Aciclovir Drug Interactions to Avoid

The BNF identifies several important drug interactions with aciclovir that UK patients should be aware of before starting treatment. Whilst aciclovir generally has a low interaction potential, certain combinations require careful monitoring or dose adjustments under prescriber supervision.

Nephrotoxic medications represent the most clinically significant interaction category. Concurrent use of aciclovir with drugs such as ciclosporin, tacrolimus, or aminoglycoside antibiotics may increase the risk of kidney impairment [1]. The BNF recommends enhanced renal function monitoring when these combinations are necessary, particularly in patients receiving higher oral doses of aciclovir.

Mycophenolate mofetil, an immunosuppressant commonly prescribed after organ transplantation, shows reduced absorption when taken alongside aciclovir, potentially compromising its therapeutic effect [3]. Probenecid, used for gout management, can increase aciclovir plasma concentrations by reducing renal excretion, which may necessitate dose modification under prescriber guidance.

Monitoring Requirements for Combined Therapy

When aciclovir is prescribed alongside interacting medications, the BNF advises regular monitoring of renal function and adequate hydration to minimise adverse effects [1]. Your UK prescriber will assess your complete medication list during clinical consultation to identify potential interactions and determine the safest treatment approach for your individual circumstances.

BNF Contraindications and Precautions for Aciclovir Use

The BNF lists hypersensitivity to aciclovir or valaciclovir as the primary contraindication for treatment. Patients who have previously experienced allergic reactions to these antiviral agents should avoid aciclovir and discuss alternative cold sore treatments with their prescriber.

Caution is advised in several clinical scenarios according to BNF guidance. Patients with renal impairment require dose adjustment for oral aciclovir formulations, as the medication is primarily eliminated through the kidneys [1]. Elderly patients may be at increased risk of neurological side effects, particularly confusion and hallucinations, when receiving high-dose oral therapy.

Pregnancy and breastfeeding considerations are carefully outlined in the BNF. Whilst topical aciclovir is generally considered safe with minimal systemic absorption, oral formulations should only be used when the potential benefit outweighs any theoretical risk [4]. Aciclovir does pass into breast milk in small amounts, though the BNF notes that this is unlikely to be harmful to the infant at standard therapeutic doses.

What to Avoid When Using Aciclovir for Cold Sores

Beyond formal drug interactions, several practical considerations can optimise aciclovir effectiveness and safety. Avoid applying aciclovir cream to mucous membranes inside the mouth or eyes, as the formulation is designed specifically for external use on the lips and surrounding skin [1].

Alcohol consumption does not directly interact with aciclovir, but may compromise immune function and potentially prolong cold sore healing. The BNF does not list alcohol as a specific contraindication, though maintaining good hydration and general health supports optimal treatment outcomes.

Sharing cold sore treatments should always be avoided to prevent cross-contamination and viral transmission. Each tube of aciclovir cream is intended for single-patient use, and application should be performed with clean hands or a cotton bud to minimise bacterial contamination of the lesion site.

Foods and Supplements Considerations

The BNF does not identify specific food interactions with aciclovir, meaning the medication can be taken with or without meals. Some patients find that lysine supplements may complement antiviral therapy, though evidence remains limited and this should be discussed with your prescriber [2]. Maintaining adequate fluid intake is particularly important when using oral aciclovir formulations to support kidney function.

Aciclovir Dosing Guidelines from the BNF

For topical treatment of cold sores, the BNF recommends applying aciclovir 5% cream five times daily for 5 to 10 days, starting at the earliest sign of outbreak [1]. Each application should use a sufficient amount to cover the entire affected area, typically a small ribbon of cream approximately 1cm in length.

Oral aciclovir for herpes simplex infections is typically prescribed at 200mg five times daily or 400mg three times daily for 5 days, though this requires prescription and clinical assessment by a UK prescriber [1]. Higher doses may be indicated for immunocompromised patients or severe presentations, with dose adjustments necessary for those with reduced kidney function.

The BNF emphasises that treatment efficacy is significantly enhanced when initiated during the prodromal phase, before visible vesicles appear. Patients who experience frequent cold sore outbreaks may benefit from suppressive therapy under specialist guidance, though this represents off-label use requiring careful risk-benefit assessment [3].

Safe Aciclovir Use: BNF Safety Advice for UK Patients

The BNF provides comprehensive safety guidance to maximise treatment benefit whilst minimising potential adverse effects. Common side effects of topical aciclovir include transient stinging or burning at the application site, mild drying or flaking of skin, and occasional contact dermatitis in sensitive individuals [1].

Systemic side effects are rare with topical formulations due to minimal absorption, but oral aciclovir may occasionally cause gastrointestinal disturbances, headache, or fatigue. Serious adverse effects such as renal impairment or neurological symptoms are uncommon but require immediate medical attention if they occur [1].

Storage recommendations from the BNF specify keeping aciclovir cream below 25°C and out of direct sunlight to maintain stability. Tubes should be discarded after the treatment course is complete or if the expiry date has passed. At Cured Pharmacy, all aciclovir products are stored in optimal conditions and dispensed with full patient information leaflets to support safe use.

Our superintendent pharmacist Tarun Kumar emphasises that whilst aciclovir is available over the counter for cold sore treatment, patients with recurrent infections, immunosuppression, or uncertainty about their symptoms should seek professional assessment. Our UK-registered clinical team is available to provide personalised guidance through a free online consultation, ensuring aciclovir is the appropriate choice for your individual circumstances.

When to Seek Further Medical Advice

The BNF advises seeking medical attention if cold sores do not improve within 10 days of treatment, if symptoms worsen despite aciclovir use, or if you develop signs of bacterial superinfection such as increasing pain, spreading redness, or purulent discharge [1]. Patients experiencing their first cold sore outbreak should also consult a healthcare professional to confirm the diagnosis and rule out other conditions.

Scientific References

1. Joint Formulary Committee. (2024). British National Formulary (BNF) 87. London: BMJ Group and Pharmaceutical Press.
2. Spruance, S. L., et al. (2002). Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: a double-blind, dose-ranging, placebo-controlled, multicenter trial. Journal of Infectious Diseases, 185(9), 1211-1218. https://doi.org/10.1086/340041
3. Medicines and Healthcare products Regulatory Agency. (2023). Aciclovir: Drug Safety Update. London: MHRA.
4. Pasternak, B., & Hviid, A. (2010). Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA, 304(8), 859-866. https://doi.org/10.1001/jama.2010.1206

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.